Li H. Li

1.8k total citations
21 papers, 1.4k citations indexed

About

Li H. Li is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Li H. Li has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Cancer Research. Recurrent topics in Li H. Li's work include Cancer therapeutics and mechanisms (7 papers), Synthesis and Biological Activity (4 papers) and Synthesis and biological activity (3 papers). Li H. Li is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Synthesis and Biological Activity (4 papers) and Synthesis and biological activity (3 papers). Li H. Li collaborates with scholars based in United States. Li H. Li's co-authors include Kenneth L. Rinehart, Sandra L. Kuentzel, Paul A. Keifer, David G. Martin, Nancy L. Fregeau, Justin G. Stroh, Tom G. Holt, Fu-Rong Sun, William C. Krueger and J. Patrick McGovren and has published in prestigious journals such as Science, Journal of the American Chemical Society and The Journal of Organic Chemistry.

In The Last Decade

Li H. Li

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li H. Li United States 17 642 435 432 414 373 21 1.4k
George R. Pettit United States 21 746 1.2× 359 0.8× 382 0.9× 628 1.5× 177 0.5× 26 1.5k
S. A. MIZSAK United States 23 983 1.5× 300 0.7× 611 1.4× 1.1k 2.6× 198 0.5× 92 2.0k
Zbigniew A. Cichacz United States 21 440 0.7× 669 1.5× 443 1.0× 540 1.3× 136 0.4× 33 1.2k
Hao Sun United States 30 883 1.4× 491 1.1× 486 1.1× 792 1.9× 199 0.5× 63 2.0k
Patricia M. Flatt United States 18 907 1.4× 623 1.4× 783 1.8× 429 1.0× 139 0.4× 19 1.8k
Andrés Francesch Spain 23 599 0.9× 490 1.1× 485 1.1× 906 2.2× 369 1.0× 57 1.8k
Greg O. Buchanan United States 12 944 1.5× 462 1.1× 716 1.7× 466 1.1× 127 0.3× 18 1.6k
Shinichi Sakemi Japan 17 338 0.5× 390 0.9× 394 0.9× 581 1.4× 179 0.5× 21 1.2k
Fred E. Boettner United States 13 449 0.7× 318 0.7× 348 0.8× 515 1.2× 81 0.2× 17 1.1k
Ashok D. Patil United States 20 562 0.9× 533 1.2× 490 1.1× 1.5k 3.5× 156 0.4× 38 2.1k

Countries citing papers authored by Li H. Li

Since Specialization
Citations

This map shows the geographic impact of Li H. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li H. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li H. Li more than expected).

Fields of papers citing papers by Li H. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li H. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li H. Li. The network helps show where Li H. Li may publish in the future.

Co-authorship network of co-authors of Li H. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Li H. Li. A scholar is included among the top collaborators of Li H. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li H. Li. Li H. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhuyan, Bijoy K., et al.. (1992). Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects. Cancer Chemotherapy and Pharmacology. 30(5). 348–354. 21 indexed citations
2.
Li, Li H. & William C. Krueger. (1991). The biochemical pharmacology of nogalamycin and its derivatives. Pharmacology & Therapeutics. 51(2). 239–255. 20 indexed citations
3.
Li, Li H., Robert C. Kelly, Martha A. Warpehoski, et al.. (1991). Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065. Investigational New Drugs. 9(2). 137–148. 66 indexed citations
4.
Rinehart, Kenneth L., Tom G. Holt, Nancy L. Fregeau, et al.. (1990). Bioactive Compounds from Aquatic and Terrestrial Sources. Journal of Natural Products. 53(4). 771–792. 98 indexed citations
5.
Rinehart, Kenneth L., Tom G. Holt, Nancy L. Fregeau, et al.. (1990). Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. The Journal of Organic Chemistry. 55(15). 4512–4515. 364 indexed citations
6.
Li, Li H., et al.. (1987). Drug sensitivity of ten human tumor cell lines compared to mouse leukemia (L1210) cells. Investigational New Drugs. 5(3). 219–229. 6 indexed citations
7.
Bhuyan, Bijoy K., et al.. (1986). Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture.. PubMed. 46(4 Pt 1). 1688–93. 81 indexed citations
8.
Li, Li H., Tanya L. Wallace, Karen A. Richard, & Daniel E. Tracey. (1985). Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.. PubMed. 45(2). 532–8. 29 indexed citations
9.
Li, Li H., et al.. (1984). Mechanism of action of didemnin B, a depsipeptide from the sea. Cancer Letters. 23(3). 279–288. 47 indexed citations
10.
Li, Li H., et al.. (1984). Biological evaluation of stability of 5-azacytidine.. The Journal of Antibiotics. 37(4). 419–421. 2 indexed citations
11.
Li, Li H., et al.. (1984). Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones.. PubMed. 44(7). 2841–7. 11 indexed citations
12.
Crampton, Sheri L., et al.. (1984). Biochemical and cellular effects of didemnins A and B.. PubMed. 44(5). 1796–801. 63 indexed citations
13.
Swenson, David H., Li H. Li, Laurence H. Hurley, et al.. (1982). Mechanism of interaction of CC-1065 (NSC 298223) with DNA.. PubMed. 42(7). 2821–8. 93 indexed citations
14.
Harbour, Gary C., Adrienne A. Tymiak, Kenneth L. Rinehart, et al.. (1981). Ptilocaulin and isoptilocaulin, antimicrobial and cytotoxic cyclic guanidines from the Caribbean sponge Ptilocaulis aff. P. spiculifer (Lamarck, 1814). Journal of the American Chemical Society. 103(18). 5604–5606. 52 indexed citations
15.
Richardson, Carol L., et al.. (1981). Template specificity of DNA binding by nogalamycin and its analogs utilizing competitive fluorescence polarization.. PubMed. 41(6). 2235–40. 10 indexed citations
16.
Rinehart, Kenneth L., et al.. (1980). Streptovaricin U, an acyclic ansamycin.. The Journal of Antibiotics. 33(2). 249–251. 16 indexed citations
17.
Li, Li H., et al.. (1979). Comparative biological and biochemical effects of nogalamycin and its analogs on L1210 leukemia.. PubMed. 39(12). 4816–22. 52 indexed citations
18.
Carter, Guy T., et al.. (1978). Brominated indoles from. Tetrahedron Letters. 19(46). 4479–4482. 49 indexed citations
19.
Kakinuma, Shizuko, et al.. (1976). Chemistry and biochemistry of the streptovaricins. XV. Protostreptovaricins I-V. Journal of the American Chemical Society. 98(3). 870–872. 25 indexed citations
20.
Rinehart, Kenneth L., Frederick J. Antosz, Shizuko Kakinuma, et al.. (1976). Identification and preparation of damavaricins, biologically active precursors of streptovaricins.. The Journal of Antibiotics. 29(2). 201–203. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George R. Pettit Breakdown of academic impact, for papers by S. A. MIZSAK Breakdown of academic impact, for papers by Zbigniew A. Cichacz Breakdown of academic impact, for papers by Hao Sun Breakdown of academic impact, for papers by Patricia M. Flatt Breakdown of academic impact, for papers by Andrés Francesch Breakdown of academic impact, for papers by Greg O. Buchanan Breakdown of academic impact, for papers by Shinichi Sakemi Breakdown of academic impact, for papers by Fred E. Boettner Breakdown of academic impact, for papers by Ashok D. Patil
Rankless by CCL
2026